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Neuregulin-1 controls an endogenous repair
mechanism after spinal cord injury
Katalin Bartus,1 Jorge Galino,2, Nicholas D. James,1, Luis R. Hernandez-Miranda,3
John M. Dawes,2 Florence R. Fricker,2 Alistair N. Garratt,3,4 Stephen B. McMahon,1
Matt S. Ramer,5 Carmen Birchmeier,3 David L. H. Bennett2,# and Elizabeth J. Bradbury1,#
,#These authors contributed equally to this work.
Following traumatic spinal cord injury, acute demyelination of spinal axons is followed by a period of spontaneous remyelination.
However, this endogenous repair response is suboptimal and may account for the persistently compromised function of surviving
axons. Spontaneous remyelination is largely mediated by Schwann cells, where demyelinated central axons, particularly in the dorsal
columns, become associated with peripheral myelin. The molecular control, functional role and origin of these central remyelinating
Schwann cells is currently unknown. The growth factor neuregulin-1 (Nrg1, encoded by NRG1) is a key signalling factor controlling
myelination in the peripheral nervous system, via signalling through ErbB tyrosine kinase receptors. Here we examined whether Nrg1
is required for Schwann cell-mediated remyelination of central dorsal column axons and whether Nrg1 ablation inﬂuences the degree
of spontaneous remyelination and functional recovery following spinal cord injury. In contused adult mice with conditional ablation
of Nrg1, we found an absence of Schwann cells within the spinal cord and profound demyelination of dorsal column axons. There
was no compensatory increase in oligodendrocyte remyelination. Removal of peripheral input to the spinal cord and proliferation
studies demonstrated that the majority of remyelinating Schwann cells originated within the injured spinal cord. We also examined
the role of speciﬁc Nrg1 isoforms, using mutant mice in which only the immunoglobulin-containing isoforms of Nrg1 (types I and II)
were conditionally ablated, leaving the type III Nrg1 intact. We found that the immunoglobulin Nrg1 isoforms were dispensable for
Schwann cell-mediated remyelination of central axons after spinal cord injury. When functional effects were examined, both global
Nrg1 and immunoglobulin-speciﬁc Nrg1 mutants demonstrated reduced spontaneous locomotor recovery compared to injured con-
trols, although global Nrg1 mutants were more impaired in tests requiring co-ordination, balance and proprioception. Furthermore,
electrophysiological assessments revealed severely impaired axonal conduction in the dorsal columns of global Nrg1 mutants (where
Schwann cell-mediated remyelination is prevented), but not immunoglobulin-speciﬁc mutants (where Schwann cell-mediated remye-
lination remains intact), providing robust evidence that the profound demyelinating phenotype observed in the dorsal columns of
Nrg1 mutant mice is related to conduction failure. Our data provide novel mechanistic insight into endogenous regenerative processes
after spinal cord injury, demonstrating that Nrg1 signalling regulates central axon remyelination and functional repair and drives the
trans-differentiation of central precursor cells into peripheral nervous system-like Schwann cells that remyelinate spinal axons after
injury. Manipulation of the Nrg1 system could therefore be exploited to enhance spontaneous repair after spinal cord injury and
other central nervous system disorders with a demyelinating pathology.
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Introduction
Spinal cord injury comprises many pathological events and
leads to devastating deﬁcits in bodily functions. Apart from
loss of motor function and paralysis, many patients also
suffer incontinence (Potter, 2006), chronic pain
(Ravenscroft et al., 2000) and psychiatric disorders
(Chevalier et al., 2009). The ﬁnancial burden of spinal
cord injury is staggering, with healthcare costs among the
highest of any medical condition (Cannon, 2013) and im-
proving neurological outcome after spinal cord injury re-
mains a major clinical challenge (Dietz and Fouad, 2014;
Ramer et al., 2014).
The complex pathophysiology of spinal cord injury is
biphasic, comprising primary trauma followed by second-
ary injury progression. Initial tissue disruption, haemorrha-
ging and oxidative stress are followed by inﬂammation,
death of neurons and glia, axonal demyelination and de-
generation, extracellular matrix remodelling, glial scar for-
mation, and cavitation (Schwab and Bartholdi, 1996; Hagg
and Oudega, 2006; Fitch and Silver, 2008; Gaudet and
Popovich, 2014). Targeting any of these injury-induced re-
active changes, singularly or in combination, may contrib-
ute to improved neurological outcome after spinal cord
injury and lead to new therapeutic strategies (Oudega et
al., 2012; Ramer et al., 2014). Despite the severe neuro-
logical deﬁcits, some degree of spontaneous, but incom-
plete, functional recovery is observed in almost all cases
(Fawcett et al., 2007). In terms of underlying biology, it
is apparent that a number of spontaneous regenerative
events occur after spinal cord injury, including neurogen-
esis, plasticity and remyelination of spinal axons (Beattie et
al., 1997; Raineteau and Schwab, 2001; Weidner and
Tuszynski, 2002; Hagg and Oudega, 2006). It is crucial
to better understand the cellular and molecular mechanisms
underlying these spontaneous repair events, which might
provide a route to enhance them directly and to design
combinations of effective therapeutic interventions.
Sparing of some subpial axon-containing spinal tissue
around the lesion core is a typical feature of traumatic
spinal cord injury (Crowe et al., 1997; Norenberg et al.,
2004; Guest et al., 2005). In the spared tissue, viable axons
are observed but these are unable to conduct under normal
physiological conditions (Koles and Rasminsky, 1972;
Nashmi and Fehlings, 2001; James et al., 2011). This
axonal impairment is associated with acute and profound
demyelination of spinal axons after traumatic contusion-
type spinal cord injuries (Bunge et al., 1960; James et al.,
2011; Plemel et al., 2014; Papastefanaki and Matsas,
2015), which are the most common form of spinal cord
injury suffered by humans (Norenberg et al., 2004).
Apoptotic loss of oligodendrocytes and gradual myelin deg-
radation are among the major events that follow primary
damage in rodents and humans (Crowe et al., 1997; Beattie
et al., 2002; Buss et al., 2005). Remyelination of demyeli-
nated axons within the injury penumbra is an important
regenerative process described in several animal models of
spinal cord injury (Bunge et al., 1961; McDonald and
Belegu, 2006; James et al., 2011; Plemel et al., 2014;
Papastefanaki and Matsas, 2015). However, this endogen-
ous repair is suboptimal and incomplete. Chronically
demyelinated axons have been reported in animal models
(Blight and Decrescito, 1986; Waxman, 1989; James et al.,
2011) and are observed up to a decade after human spinal
cord injury (Bunge et al., 1993; Guest et al., 2005). Myelin
integrity is essential for CNS physiology, allowing ﬁne
tuning of motor skills and sensory integration, and there
is evidence that remyelination restores efﬁcient signal con-
duction and functional outcome (Smith et al., 1979;
Duncan et al., 2009) and is crucial for axonal protection
and metabolic support (Franklin and Ffrench-Constant,
2008; Irvine and Blakemore, 2008). Strategies to prevent
demyelination at early stages and to accelerate and enhance
myelin repair at later stages are an important part of the
wide spectrum of promising therapies for spinal cord injury
(Plemel et al., 2014; Ramer et al., 2014; Papastefanaki and
Matsas, 2015).
An interesting phenomenon in the injured CNS is remye-
lination of central axons by Schwann cells, which are nor-
mally excluded from the CNS and represent the primary
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myelinating cells in the peripheral nervous system (PNS).
This unexplained intrinsic myelin repair is also observed in
the chronically injured human spinal cord, where demyeli-
nated axons become associated with peripheral myelin,
most noticeably in the dorsal columns (Bunge et al.,
1993; Guest et al., 2005). Evidence demonstrates that
Schwann cells that myelinate CNS axons produce func-
tional and stable myelin that has normal properties
(Blight and Young, 1989; Felts and Smith, 1992, 1996).
In addition, in the remyelinated axons the composition of
the nodes of Ranvier is normal (Black et al., 2006). Two
distinct mechanisms might account for the presence of ‘cen-
tral’ Schwann cells: peripheral Schwann cells might enter
the spinal cord as a result of injury to the transition zone
between PNS/CNS and/or they may be derived from CNS-
resident oligodendrocyte precursors by (trans)-differenti-
ation (Sims et al., 1998; Jasmin et al., 2000; Zawadzka
et al., 2010; Perlin et al., 2011). Independent of the cellular
mechanisms, molecular mechanisms that govern the
Schwann cell-mediated remyelination of injured spinal
axons are unknown. Understanding the molecular events
involved in this process is important and could be exploited
to enhance function of surviving axons, or improve func-
tion of regenerating axons, in the injured spinal cord and
thus improve functional recovery. Such mechanisms might
also promote repair in other CNS disorders that involve a
demyelinating pathology.
The growth factor neuregulin 1 (Nrg1, encoded by
NRG1), which signals via ErbB tyrosine kinase receptors,
is crucial for Schwann cell development and function in the
PNS. Nrg1 stimulates survival of precursors, migration of
Schwann cells, ensheathment, myelination and remyelina-
tion of peripheral axons (Birchmeier and Nave, 2008;
Fricker and Bennett, 2011; Stassart et al., 2013; Nave
and Werner, 2014). There are over 30 different Nrg1 iso-
forms, all of which possess an epidermal growth factor
(EGF)-like signalling domain essential for receptor binding
and biological activity. Isoforms differ in their functional
role and expression and can be classiﬁed according to the
structure of their N termini (Falls, 2003; Newbern and
Birchmeier, 2010). Isoforms containing an immunoglobulin
(Ig)-like domain (types I and II) can be either directly se-
creted or released as soluble proteins from the cell surface
after proteolytic cleavage. Isoforms possessing a cysteine-
rich domain (type III isoforms) have two transmembrane
domains and require proteolytic cleavage by BACE1 (b-site
APP-cleaving enzyme 1) for full activity. In vivo these iso-
forms are thought to be retained on the cell membrane and
signal in a juxtacrine manner (Hu et al., 2006; Willem et
al., 2006) although type III isoforms can undergo dual
cleavage by BACE1 and ADAM17 to release the EGF
domain, which signals in a paracrine fashion (Fleck et al.,
2013). We hypothesized that Nrg1 may be a key regulatory
factor for spontaneous remyelination of injured axons in
the CNS by Schwann cells. Nrg1 is also known to modu-
late oligodendrocyte function (Brinkmann et al., 2008;
Taveggia et al., 2008; Makinodan et al., 2012;
Lundgaard et al., 2013) and neural precursor cells in the
spinal cord have been shown to be responsive to Nrg1, as
exogenous Nrg1 promotes oligodendrocyte production and
repair (Zhang et al., 2011; Gauthier et al., 2013). To de-
termine the mechanisms controlling remyelination of CNS
axons by Schwann cells after spinal cord injury and to
avoid confounds of the developmental functions, we intro-
duced Nrg1 mutation in adult mice using a tamoxifen in-
ducible Cre (Meyer and Birchmeier, 1995; Fricker et al.,
2013). To determine the importance of Nrg1 in repair,
we used a clinically relevant spinal cord contusion injury
model (James et al., 2011), and compared myelination in
the injured spinal cord and functional outcome in the pres-
ence and absence of Nrg1. To determine the importance of
speciﬁc Nrg1 isoforms in Schwann cell-mediated remyelina-
tion after traumatic spinal cord injury, we also examined
this regenerative process after ablating Ig-containing iso-
forms of Nrg1 (IgNrg1) only, which leaves the type III
Nrg1 intact.
We demonstrate that Nrg1 is essential for remyelination
of dorsal column axons by PNS-like Schwann cells and that
an absence of Nrg1 elicits a profound and persistent
demyelinating phenotype and axonal conduction failure
after spinal cord injury. IgNrg1 isoforms are dispensable
for this process, implicating type III Nrg1 as the key iso-
form mediating this process. We also provide evidence that
the majority of centrally remyelinating Schwann cells derive
from newly generated precursor cells within the spinal
cord. Interference with Nrg1 signalling also signiﬁcantly
impacts the degree of spontaneous locomotor recovery
after contusive spinal cord injury. These data reveal that
Nrg1 signalling mediates an endogenous regenerative event
in which Schwann cells remyelinate denuded central axons
after traumatic spinal cord injury and that Nrg1 is an im-
portant mediator of spontaneous functional repair after
spinal cord injury.
Materials and methods
Animals
All animal work carried out conformed to UK Home Ofﬁce
legislation (Scientiﬁc Procedures Act 1986). CAG-Cre-ERTM;
Nrg1ﬂ/ﬂ mice, and CAG-Cre-ERTM; IgNrg1ﬂ/ﬂ were bred by
crossing Nrg1ﬂ/ﬂ mice and IgNrg1ﬂ/ﬂ with CAG-Cre-ERTM
mice [JAX(r) mice 004682], respectively; as described previ-
ously (Cheret et al., 2013; Fricker et al., 2013). The generation
and genotyping of mutant mice with ﬂoxed alleles of Nrg1
(Nrg1ﬂ/ﬂ) mice has previously been described (Yang et al.,
2001; Brinkmann et al., 2008; Fricker et al., 2013). These
mice are null for -isoforms of Nrg1 in the absence of Cre
recombination as they carry a premature stop codon in exon
7, which encodes the -EGF domain (Li et al., 2002). The loxP
sites ﬂank exons 7–9, and exon 8 encodes the b-EGF domain.
Cre recombination therefore results in ablation of all remain-
ing b isoforms. CAG-Cre-ERTM construct detection and ex-
pression evaluation is described previously (Fricker et al.,
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2013). The generation and genotyping of IgNrg1ﬂ/ﬂ has been
described previously (Cheret et al., 2013); brieﬂy, mutant al-
leles have the exon 4 ﬂanked by loxP sites, exons 3 and 4 of
Nrg1 encode the Ig-like domain, mutations speciﬁcally inter-
fere with the production of IgNrg1 forms (i.e. Nrg1 type I and
Nrg1 type II), but not CRD-Nrg1 transcripts. In CAG-Cre-
ERTM mice, a tamoxifen inducible form of Cre recombinase
is expressed ubiquitously driven by a chimeric promoter con-
structed from a cytomegalovirus intermediate-early enhancer
and a chicken b actin promoter/enhancer (Hayashi and
McMahon, 2002). Conditional Nrg1 (conNrg1 mutant) and
conIgNrg1 mice were generated by administering tamoxifen
(Sigma T5648, 0.25mg/g body weight in corn oil) by oral
gavage for ﬁve consecutive days to 10-week-old CAG-Cre-
ERTM; Nrg1ﬂ/ﬂ and CAG-Cre-ERTM; IgNrg1ﬂ/ﬂ mice respect-
ively. Tamoxifen was administered 4 weeks prior to surgery.
We have previously assessed Nrg1 expression in conNrg1
mutant within spinal cord at 4 weeks following this treatment
regimen: conNrg1 demonstrate a 83% reduction in the expres-
sion of the bEGF domain of Nrg1 (which is critical for biolo-
gical activity of all isoforms) relative to control (Fricker et al.,
2013) and on assessment of the most abundant Nrg1 type III
isoform protein there was a signiﬁcant reduction in both the
full length and the cleaved C-terminal fragment. For experi-
ments with CAG-Cre-ERTM; Nrg1ﬂ/ﬂ two types of control ani-
mals were used for comparison: vehicle controls, which were
CAG-Cre-ERTM; Nrg1ﬂ/ﬂ littermates treated with corn oil
alone or tamoxifen control, which were tamoxifen treated
Nrg1ﬂ/ﬂ littermates. For experiments with CAG-Cre-ERTM;
IgNrg1ﬂ/ﬂ mice we used tamoxifen control littermates.
Wherever possible, we included equal numbers of animals of
each gender in each experimental group.
Spinal contusion injury
Mice
Mice were anaesthetized with isoﬂurane, their backs were
shaved and cleansed, and core temperature was maintained
close to 37 C using a self-regulating heated blanket. Single
doses of 0.05mg/kg buprenorphine and 5mg/kg carprofen
were administered subcutaneously at the time of induction
and the morning after surgery. Animals underwent midthor-
acic laminectomy and received a moderate midline 50 kdyne
spinal contusion injury through the intact dura at spinal level
T10/11 using an Inﬁnite Horizon’s impactor (Precision Systems
Instrumentation). Overlying muscle and skin were sutured in
layers, subcutaneous saline was administered, and animals
were left to recover from anaesthesia in a 37 C incubator.
Saline and enroﬂoxacin (5mg/kg) were given subcutaneously
daily for 3 and 7 days, respectively, after injury. Bladders were
manually expressed three to four times daily during the ﬁrst 2
to 3 days after surgery and twice daily thereafter until the end
of the study period.
Rats
Adult female Sprague Dawley rats (150–200 g; Harlan
Laboratories) were used, housed under a 12-h light/dark
cycle with ad libitum access to food and water. Animals
were anaesthetized using a mixture of ketamine (60mg/kg)
and medetomidine 0.25mg/kg, administered intraperitoneally.
Following midthoracic laminectomy to expose the spinal cord
leaving the dura intact, animals received a moderate midline
150 kdyne spinal contusion injury at spinal level T10/11 using
an Inﬁnite Horizon’s impactor (Precision Systems
Instrumentation) (James et al., 2011). Postoperative care was
performed as above with the exception that bladders were
manually expressed twice daily until reﬂexive emptying re-
turned (typically 6 to 9 days after injury).
Spinal contusion injury with dorsal
root removal
Adult female Sprague Dawley rats (150–200 g; Harlan
Laboratories) were used and contusion surgeries and post-
operative care were performed as described above. One
cohort of animals received moderate 150 kdyne T10/T11 con-
tusions (n = 6) only. A second cohort of animals received mod-
erate 150 kdyne T10/T11 contusions followed by bilateral
dorsal root removal at thoracic levels T9 to T11/T12 (n = 8).
To ascertain complete removal, roots were post-ﬁxed overnight
in 4% paraformaldehyde in 0.1 M phosphate buffer and
whole mounts were prepared for immunostaining for glial ﬁ-
brillary acidic protein (GFAP) to label reactive astrocytes in the
region of the dorsal root entry zone (rabbit polyclonal anti-
GFAP, 1:2000, DakoCytomation). This experiment was car-
ried out in rats due to the complexity of the surgery and
low survival rate of mice (mainly caused by blood loss follow-
ing lateral bone removal that is necessary to sufﬁciently expose
roots). However, electron microscopy data and immunohisto-
chemistry conﬁrmed that the pattern and time course of
Schwann cell-mediated remyelination is the same in mice and
rats (James et al., 2011; and see Figs 2 and 5).
Behavioural assessments
Basso Mouse Scale
The Basso Mouse Scale (BMS) (Basso et al., 2006) was used to
assess open ﬁeld hindlimb locomotor function (n = 7–9 per
group). This involved placing the animal in a circular open
ﬁeld (diameter 1 m) and assessing both hindlimbs during
locomotion (over a 4-min session). Scores were calculated ac-
cording to the 10 point (0–9) BMS scale. For further detailed
assessments of differences between conNrg1 and conIgNrg1
null mice in additional cohorts of animals, mice were assessed
with the 12 point (0–11) BMS subscore scale, which further
delineates recovery of speciﬁc locomotor features that may not
be apparent in the overall BMS score (such as quantifying
improvements in the areas of stepping frequency, coordination,
paw position, trunk stability, and tail position). Testing was
performed by two experimenters blinded to the treatment
groups on Days 2, 5 and 7 after injury and once weekly there-
after for 8 weeks, followed by sacriﬁcing animals for immu-
nohistochemical and ultrastructural analysis. All BMS
behavioural data are presented as mean  standard error of
the mean (SEM) values and statistical signiﬁcance was ac-
cepted with P50.05 using two-way ANOVA with
Bonferroni post hoc tests (BMS score) or one-way ANOVA
with Tukey’s post hoc tests (BMS subscore).
Inclined beam-walking test
For further detailed assessments of differences between
conNrg1 and conIgNrg1 null mice, animals were also assessed
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on the inclined beam walking test. Beam-walking apparatus
consisted of an inclined beam (100 cm) ﬁxed to a black ‘goal
box’. The horizontal inclined beam consisted of a ﬂat surface
that gradually narrowed (1.5 cm at the widest; 0.5 cm at the
narrowest) and a small ledge underneath on either side.
Animals were trained for seven consecutive days before base-
line readings were obtained. Left and right hind limb scores
were calculated based on number of weight supported steps
taken on the beam as well as lower scores for steps taken on
the small ledges. The beam was divided into quarters; one
point was scored for a weight supported step on the beam
in the ﬁrst broadest division. This score was doubled, tripled
or quadrupled in the second, third and fourth sections of the
beam due to the increased difﬁculty of the tapered beam. In all
sections one point was scored for a step taken on the small
ledges. Data (n = 6–9 per group) are presented as mean  SEM
values and statistical signiﬁcance was accepted with P50.05
using one-way ANOVA with Tukey’s post hoc tests.
Electrophysiology
To carry out electrophysiological assessment of dorsal column
function, mice were deeply anaesthetized with urethane
[0.1ml/10 g of 12.5% solution administered intraperitoneally
(i.p.)] and depth of anaesthesia was regularly assessed by
monitoring withdrawal reﬂexes and respiratory rate. Core tem-
perature was maintained close to 37 C using a self-regulating
heating pad. A laminectomy was performed to expose spinal
tissue from 5mm rostral to 5mm caudal of the contusion
injury site. The sural nerve of the left hindlimb was exposed
and freed from connective tissue, and all nervous tissue was
covered with mineral oil. Silver ball stimulating electrodes were
then placed at 5mm rostral and 5mm caudal of the injury site
and a pair of silver wire recording electrodes was hooked
underneath the sural nerve with a separation of 3mm be-
tween the wires. To assess the extent of sensory conduction
through the spinal contusion injury site, recordings were made
from the sural nerve (an almost exclusively sensory nerve)
while ﬁrst stimulating the spinal cord caudal to the lesion
and then repeating this procedure whilst stimulating rostral
to the lesion site. Stimulation was delivered in 250 ms square
wave pulses at a frequency of 0.5Hz and at a supramaximal
intensity (typically 600–800 mA). Amplitude analysis was car-
ried out on traces averaged from 16 recordings taken follow-
ing stimulation at each site (rostral or caudal to lesion). The
peak-to-peak amplitude of the averaged potential recorded
whilst stimulating rostral to the lesion site was then calculated
as a percentage of the averaged potential recorded whilst sti-
mulating caudal to the lesion, thus estimating the percentage of
sensory ﬁbres in the sural nerve projecting beyond the injury
site that remain capable of conduction. Although the stimula-
tion technique used here is likely to have activated more than
just the ﬁbres of the dorsal columns, the sural nerve is almost
exclusively composed of sensory ﬁbres and therefore only the
activity of long distance afferent ﬁbres will be recorded using
this protocol. All recordings were made using a PowerLab unit
(AD Instruments) and amplitude analysis was carried out using
LabChart 8 software (AD Instruments). Data (n = 5–6 per
group) are presented as mean  SEM values and statistical sig-
niﬁcance was accepted with P50.05 using one-way ANOVA
with Tukey’s post hoc test.
Tissue preparation and
immunohistochemistry
Animals were deeply anaesthetized with sodium pentobarbital
(Euthatal: 80mg/kg, i.p) and transcardially perfused with
phosphate-buffered saline (PBS) (containing heparin) followed
by 4% paraformaldehyde in 0.1 M phosphate buffer contain-
ing 1.5% picric acid. Immediately after perfusion, lesion site
tissue was dissected (10mm with the lesion epicentre located
centrally). Tissue was post-ﬁxed overnight at 4 C, cryopro-
tected in 20% sucrose for 48–72 h, then embedded and
frozen in O.C.T. before being cut into serial transverse (20
mm) sections. Sections were immunostained using the following
primary antibodies: rabbit polyclonal anti-glial ﬁbrillary acidic
protein (GFAP) to label reactive astrocytes (1:2000,
DakoCytomation), chicken polyclonal anti-protein zero (P0)
to label Schwann cell-associated myelin (1:500, Abcam),
chicken polyclonal anti-proteolipid protein (PLP) to label
oligodendrocyte-associated myelin (1:200, Millipore), rabbit
polyclonal anti-neuroﬁlament 200 (NF200) to label axons
(1:200, Sigma), rabbit polyclonal anti-laminin to visualize
Schwann cell basal lamina (1:1000, Dako), and rabbit poly-
clonal anti-Olig2, a marker for oligodendrocytes (1:500,
Millipore). Complementary secondary antibodies were goat
anti-chicken biotin (1:400, Abcam), ExtrAvidin FITC conju-
gate (1:500, Sigma), goat anti-chicken Alexa 488 (1:1000,
Invitrogen), goat anti-rabbit Alexa 568 (1:1000, Invitrogen)
and goat anti-rabbit Alexa 488 (1:1000, Invitrogen). Brieﬂy,
after blocking with 10% goat serum in PBS containing 0.2%
TritonTM X-100 (PBST) for 1 h at room temperature, the sec-
tions were incubated in PBST containing primary antibodies
overnight at room temperature. After four washes of 5min
with PBS, sections were incubated in PBST containing comple-
mentary secondary antibodies for 4 h at room temperature.
After four washes of 5min in PBS, sections were coverslipped
with Vectashield mounting medium (Vector Laboratories).
Images were acquired using Nikon A1R Si Confocal Imaging
system on an Eclipse Ti-E inverted microscope.
For haematoxylin and eosin staining, spinal sections were
rinsed in tap water, stained with haemalum for 5min and
then rinsed in running tap water until clear. Slides were then
dipped ﬁve times into 0.5% hydrochloric acid in 70% IMS
(acid-alcohol) and quickly returned to running tap water for
1min, placed in eosin for 5min, returned to tap water, dehy-
drated and mounted using DPX. Using this technique, nuclei
and any basophilic components are labelled blue, while com-
ponents such as cytoplasm and collagen are labelled as shades
of pink-orange.
Labelling of cellular DNA with EdU
and EdU staining
Wild-type mice (n = 3) received spinal contusion injuries, as
above, followed by administration of 5-ethynyl-2’-deoxyuri-
dine (EdU, Invitrogen) (Salic and Mitchison, 2008; Zeng et
al., 2010), administered by intraperitoneal injection (200 mg
per injection) for 10 consecutive days beginning at 24 h post-
injury. Control uninjured mice (n = 3) received the equivalent
EdU dosing paradigm. At 4 weeks post-injury mice were
deeply anaesthetized with sodium pentobarbital (Euthatal:
80mg/kg, i.p) and transcardially perfused with PBS (containing
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heparin) followed by 4% paraformaldehyde in 0.1 M phos-
phate buffer, and spinal cords were harvested and prepared for
immunohistochemistry. Tissue was post-ﬁxed with 4% paraf-
ormaldehyde in 0.1 M PBS for 3 h at 4 C, cryoprotected for
24 h at 4 C in 30% sucrose in PBS prior to embedding and
sectioned at 30-mm thickness. EdU staining was conducted
using the Click-iTTM EdU imaging kit (Invitrogen) according
to the manufacturer’s protocol but adapted for immunohisto-
chemical double-staining of spinal cord tissue. Slides contain-
ing mounted frozen spinal cord sections were allowed to thaw,
and then rehydrated with PBS. After rehydration with PBS the
sections were incubated in 10% normal donkey serum perme-
abilization/blocking buffer made in PBS containing 0.3%
TritonTM X-100 for 15min. This was followed by one PBS
rinse and incubation with EdU detection solution (Invitrogen)
for 1 h at room temperature. Slides were then washed three
times with PBS before incubation with permeabilization/block-
ing buffer overnight at room temperature. Subsequently, pri-
mary antibodies made in PBST to label either P0 or PLP were
incubated overnight for 24 h at room temperature. After four
washes of 5min with PBS, sections were incubated in PBST
containing complementary secondary antibodies for 4 h at
room temperature. After four washes of 5min in PBS, sections
were coverslipped with Vectashield mounting medium (Vector
Laboratories). Images were acquired using Nikon A1R Si
Confocal Imaging system on an Eclipse Ti-E inverted
microscope.
Immunohistochemistry image
analysis
Quantiﬁcation of P0 and PLP in mouse spinal cords (n = 4–5
per group) was carried out by measuring the immunopositive
areas in the dorsal column (AxioVision LE software), which
were then expressed as % of total dorsal column area. Total
dorsal column area was measured by taking the mean area of
intact dorsal column, measured rostral and caudal to the lesion
site. Quantiﬁcation of P0 in the lesion epicentre in rat spinal
cords with or without multiple dorsal root removal (n = 4–5
per group) was carried out by measuring the immunopositive
P0 cluster in the dorsal column, which was then expressed as
per cent of total dorsal column area as above. Quantiﬁcation
of Olig2 (n = 3 per group) was carried out by unbiased particle
counts following background subtraction (ImageJ software).
Images were acquired sequentially, using the same exposure
parameters. All anatomical quantiﬁcation was carried out by
an experimenter blinded to the treatment group and data are
expressed as mean  SEM values, using one-way ANOVA
with Tukey’s post hoc tests.
Electron microscopy
Animals were terminally anaesthetized using sodium pentobar-
bital (Euthatal; 80mg/kg, i.p.) and transcardially perfused with
0.9% saline followed by 3% glutaraldehyde and 4% parafor-
maldehyde in 0.1 M phosphate buffer, a section of thoracic
spinal cord was removed (10mm) with the lesion epicentre
located centrally. Two to three millimetre sections were taken
from the lesion epicentre and from the rostral and caudal
lesion borders and postﬁxed in the same ﬁxative buffer (3%
glutaraldehyde and 4% paraformaldehyde in 0.1 M phosphate
buffer) for a minimum of 48 h at 4 C and processed as pre-
viously described (James et al., 2011; Fricker et al., 2013).
Semithin and ultrathin sections were cut and stained by the
Centre for Ultrastructural Imaging (King’s College London,
London, UK). Ultrathin sections were mounted on unsup-
ported gilded copper grids (150-square mesh) from TAAB
and were visualized on a Hitachi H7600 transmission electron
microscope. For analysis, photomicrographs of the region con-
taining the ascending dorsal column projection from each
animal were taken at 8000 magniﬁcation, the area of
which totalled at least 50% of the total area of the cross-sec-
tion of the dorsal column. Full montages of grid squares were
taken (100 pictures per mesh) and randomly chosen images
from a given grid square were analysed. The total number of
axons, total number of myelinated axons, Schwann cell-mye-
linated axons, and oligodendrocyte-myelinated axons (using
the criteria described in Supplementary Fig. 5) were counted
from these montages of grid squares and normalized to the
dorsal column area. To calculate G-ratios, axon diameters
and non-myelinated axons with a diameter41 mm from 30
individual pictures at 8000 magniﬁcation were randomly
chosen per animal; analysis was performed on all of the
axons within each picture and axon diameter and G-ratio
(axon diameter/ﬁbre diameter) were calculated using
AxioVision LE Rel. 4.2 Software. At least 750 axons were
measured per animal. The examiner was blind to the genotype.
The one-way ANOVA using the Tukey post hoc test was used
for comparison of more than two groups. Cumulative frequen-
cies were compared statistically using the Kolmogorov-
Smirnov test.
Fluorescence in situ hybridization and
immunohistochemistry
Uninjured (n = 3) and injured (4 weeks post-injury; n = 3) wild-
type mice were deeply anaesthetized with sodium pentobarbital
(Euthatal: 80mg/kg, i.p) and transcardially perfused with
DPEC-treated sterile PBS followed by 4% paraformaldehyde
in 0.1 M phosphate buffer, and spinal cords were harvested
and prepared for immunohistochemistry. Tissue was post-ﬁxed
with 4% paraformaldehyde in 0.1 M PBS for 3 h at 4 C,
cryoprotected for 24 h at 4 C in 30% sucrose in diethyl pyr-
ocarbonate-treated PBS prior to embedding and sectioned at
30-mm thickness. Pan-Nrg1 in situ probes (Meyer et al., 1997)
were transcribed in vitro and labelled with digoxygenin (DIG)
according to manufacturer’s instructions (Roche). Following
overnight hybridization at 65 C, sections were incubated
with anti-DIG antibodies (Roche) and developed as previously
described (Hopman et al., 1998). To examine Nrg1 expression
in different cell types, slides were then co-stained for P0, Olig2
and NeuN immunohistochemically, as described above.
Extraction of fresh tissue
Spinal cord (lesion epicentre) and L4 and 5 DRGs were ex-
tracted from animals at 1 and 4 weeks after injury, snap frozen
on liquid nitrogen and stored at80 C. The same tissue from
naı¨ve animals was used as control. Tissue samples were then
homogenized and total RNA obtained using a ‘hybrid’ method
of phenol extraction (TriPure, Roche) and column puriﬁcation
(High Pure RNA tissue Kit, Roche) according to
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manufacturer’s protocols. All samples were DNase treated to
prevent genomic contamination. RNA was subsequently
synthesized into cDNA using Transcriptor Reverse
Transcriptase (Roche) following the manufacturer’s protocol.
Quantitative polymerase chain
reaction
Quantitative PCR (qPCR) was performed using the LC 480
system. All primers used, shown in Supplementary Table 1,
had an efﬁciency of 100  10% and were designed using
primer blast unless stated otherwise. Gene expression levels
were measured using the CT method and normalized
against the reference genes Gadph and Hprt1. The relative
mRNA expression is shown as the amount of transcript in
injured samples versus naive controls. The one-way ANOVA
using the Tukey’s post hoc test was used for comparison of
more than two groups. When the values are not normally
distributed the one-way ANOVA on ranks post hoc Dunn’s
method was used.
Results
Ablation of Nrg1 prevents
spontaneous remyelination of axons
in the injured spinal cord
The molecular control of Schwann cell-mediated axonal
remyelination in the injured CNS is unknown. We asked
whether Nrg1 is required for Schwann cell-mediated remye-
lination of dorsal column axons after spinal contusion
injury, and whether Nrg1 ablation inﬂuences the degree
and nature of remyelination. We ﬁrst conﬁrmed that
there were no differences in the expression of global astro-
cyte and axonal markers (GFAP and NF200, respectively)
or in peripheral and central myelin expression (P0 and PLP,
respectively) in uninjured control mice and mice with con-
ditional Nrg1 mutations (hereafter called conNrg1 mice)
(Supplementary Fig. 1). Immunoreactivity for P0 identiﬁes
Schwann cell-derived peripheral myelin and is normally
only expressed in the PNS. As expected, P0 was detected
in the peripheral dorsal and ventral roots but was absent
from the spinal cord of all uninjured animals
(Supplementary Fig. 1A and C). However, 10 weeks after
contusive spinal cord injury, P0 was present in the dorsal
columns of the injured spinal cord in both vehicle- and
tamoxifen-treated control animals. P0 was most abundant
at the lesion epicentre, where 60% of the dorsal column
area expressed Schwann cell-associated myelin (Fig. 1A, B,
D and Supplementary Fig. 2). Strikingly, there was no P0
immunoreactivity within the injured spinal cord of
conNrg1 mice. Thus, when all Nrg1 isoforms are ablated,
Schwann cell-associated myelin in the spinal dorsal col-
umns is completely absent after injury (Fig. 1C, D and
Supplementary Fig. 2). Interestingly, the presence of
Schwann cell myelin within the spinal cord after injury
was only observed in the dorsal column region of the
spinal cord and not in other white matter tracts or in the
cellular and matrix ﬁlled lesion core (Supplementary Figs 2
and 3).
To determine whether abrogation of Schwann cell-
mediated remyelination may trigger compensatory remyeli-
nation by oligodendrocytes, we examined the expression of
PLP, the major protein of oligodendrocyte-derived myelin
which is expressed exclusively in the CNS and absent from
peripheral tissues (Supplementary Fig. 1B and D). PLP
immunohistochemistry revealed that the absence of
Schwann cell-mediated remyelination in conNrg1 mutants
did not evoke compensatory myelination by oligodendro-
cytes, with a similar pattern of PLP expression observed at
10 weeks after spinal cord injury in conNrg1, vehicle- or
tamoxifen-treated control animals (Supplementary Fig. 4).
In particular, abundant PLP staining was observed in white
matter tracts of the spinal cord throughout the rostrocaudal
axis which was dramatically reduced in the dorsal columns
at the injury epicentre (Supplementary Fig. 4D). Double
labelling revealed that areas normally associated with abun-
dant P0 immunoreactivity in control injured animals (Fig.
1A’ and B’) were positive for the axonal marker NF200 but
devoid of central myelin (Supplementary Fig. 4A’ and B’),
while in conNrg1 injured animals these areas remained
negative for both Schwann cell-derived (P0, Fig. 1C’) and
oligodendrocyte-derived (PLP, Supplementary Fig. 4C’)
myelin. To conﬁrm that there was no change in the
number of oligodendrocytes, we also assessed the expres-
sion of the transcription factor Olig2, which is an essential
regulator of oligodendrocyte development. Consistent with
unchanged distribution of PLP, no differences in Olig2 ex-
pression were observed between control and conNrg1 mice
at 4 weeks after injury (Supplementary Fig. 5A–C). At this
stage, remyelination by PNS-like Schwann cells is normally
evident (James et al., 2011; Fig. 5C and F). The profound
interference with Schwann cell-mediated remyelination of
dorsal column axons suggests that Nrg1 is a key regulator
of spontaneous myelin repair.
Ultrastructural analysis reveals
profound demyelination in the injured
spinal cord after Nrg1 ablation
We used electron microscopy to analyse at the ultrastruc-
tural level myelination in the dorsal columns of injured
control and conNrg1 mice. We observed a dramatic reduc-
tion in the number of myelinated axons in the dorsal
column in conNrg1 mice at 10 weeks post injury compared
to control mice (Fig. 2A–C and D) and a corresponding
increase in the percentage of large diameter axons (diam-
eter41 mm) that were unmyelinated (Fig. 2A–C and E).
There was no difference in axon diameter between groups
(Fig. 2H), excluding the possibility of exacerbated axonal
swelling in mice lacking Nrg1. We also assessed the effects
of Nrg1 ablation on remyelination by Schwann cells versus
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oligodendrocytes in the dorsal columns using standard
morphological criteria to differentiate these cell types
(Felts and Smith, 1996; Woodruff and Franklin, 1999)
(Supplementary Fig. 6). Only a negligible number of
axons were remyelinated by Schwann cells in the dorsal
column of conNrg1 mutant animals (Fig. 2A–C and F).
The few remyelinated axons in injured conNrg1 mice
were predominantly remyelinated by oligodendrocytes,
but a compensatory increase in oligodendrocyte remyelina-
tion was not observed (Fig. 2C and I). Furthermore, those
axons that were remyelinated by oligodendrocytes in
conNrg1 mutant animals had signiﬁcantly thinner myelin
sheaths, quantitatively measured by an increased G-ratio
(Fig. 2A–C and G). These changes were consistently
Figure 1 Ablation of Nrg1 prevents remyelination of spinal axons by Schwann cells after spinal cord injury. (A–C) Co-staining of
astrocytes (GFAP, red) and Schwann cell-associated myelin (P0, green) in serial sections of the spinal cord that span the rostrocaudal axis of the
injury in vehicle control (Vh control, A), tamoxifen control (Tx control, B) and Nrg1-ablated (conNrg1, C) contused mouse spinal cords at 10
weeks post-injury. In all animals, the peripheral myelin protein P0 is apparent outside the spinal cord, in the peripheral dorsal and ventral roots, as
expected. However, 10 weeks after contusion injury, Schwann cell-associated myelin (P0) is also observed in the spinal dorsal columns of control
animals, being particularly abundant in the epicentre of the lesion (A and B). Strikingly, P0 is absent in the spinal dorsal columns of injured mice
lacking Nrg1 (conNrg1; C). (A’–C’) High magnification of boxed areas indicated in A–C. (D) Quantification of P0-positive area in the dorsal
columns assessed in sections that span the rostrocaudal axis of the injury site reveals undetectable levels of P0 in conNrg1 mice, compared to
control groups. Data are presented as mean  SEM. (P5 0.007, two-way ANOVA, post hoc Bonferroni n = 4–5 animals/group). Scale
bars = 250 mm (C); 50 mm (C’). Images not using the red/green colour scheme are available in the Supplementary material.
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observed between different animals, demonstrating that this
striking demyelination phenotype is caused by the lack of
Nrg1. Total axon counts did not differ between groups
indicating that disruption of Nrg1 signalling had no effect
on axonal survival at 10 weeks after spinal contusion
injury (Fig. 2J).
To verify that remyelinating cells in the injured spinal
cord were indeed ‘classic’ peripheral Schwann cells rather
than type IV oligodendrocytes (which resemble peripheral
Schwann cells but lack a basal lamina; Butt et al., 1995;
Butt and Berry, 2000), we assessed the presence of laminin,
a key component of Schwann cell basal laminae. We
observed prominent ring-like laminin-positive structures in
close association with P0-positive myelin rings, indicating
the presence of basal lamina around remyelinating PNS-like
Schwann cells in the dorsal column of injured control ani-
mals (Fig. 3A–C). Strikingly, the complete absence of P0-
positive myelin rings in the dorsal column of conNrg1 mice
(Fig. 3D) was accompanied by an absence of laminin-posi-
tive rings (Fig. 3E), with only diffuse and disorganized lam-
inin apparent in this region (Fig. 3D–F), which likely
derives from other laminin-producing, but not remyelinat-
ing, cells.
Taken together, our detailed ultrastructural analysis con-
ﬁrms that Nrg1 is absolutely required for remyelination of
dorsal column axons by PNS-like Schwann cells.
Furthermore, these data imply that Nrg1 determines not
only the myelinating potential of these cells, but also their
occurrence in the injured spinal cord. Both electron micros-
copy data and immunohistochemistry support the conclu-
sion that the appearance of ‘classic’ PNS-like Schwann cells
in the injured spinal cord and the efﬁcient remyelination of
central axons occurs only in the presence of Nrg1.
Nrg1 expression in normal and
injured spinal cord
To determine the expression pattern of Nrg1 before and
after injury and the possible cellular source of neuregulin,
we performed ﬂuorescence in situ hybridization for Nrg1
using a pan-Nrg1 probe combined with double immunohis-
tochemistry for P0 and NeuN or Olig2 and NeuN (Fig. 4)
in uninjured wild-type mice (Fig. 4A–D) and contused wild-
type mice at 4 weeks post-injury (Fig. 4E–H). As predicted
from the literature (Corfas et al., 1995; Meyer et al., 1997),
the majority of Nrg1 expression in uninjured spinal cords
was neuronal, with high co-localization of Nrg1 in the
cytoplasm of numerous NeuN-positive spinal neurons
(Fig. 4A and B). Nrg1 was also apparent, although less
abundant, in spinal cord white matter; this was not co-
localized with P0, either in uninjured spinal cord where
P0 was restricted to the peripheral dorsal roots (Fig. 4A
and C), or injured spinal cord where P0 was also apparent
in the spinal cord dorsal column (Fig. 4E and G). There
was also little co-localization of Nrg1 with Olig 2 in the
uninjured (Fig. 4B and D) or injured (Fig. 4F and H) spinal
cord. Nrg1 is therefore unlikely to be having autocrine ac-
tions in Schwann cells or oligodendrocytes within the spinal
cord. The majority of Nrg1 inﬂuencing Schwann cell
remyelination is likely to be derived either from spinal neu-
rons or axons projecting through the dorsal column: large
diameter myelinated sensory neurons are known to express
Nrg1 (particularly type III Nrg1) at a high level in adult-
hood (Bermingham-McDonogh et al., 1997; Fricker et al.,
2009).
We also assessed mRNA expression of different Nrg1
isoforms and ErbB receptors, to determine whether spinal
contusion injury alters the expression of components of the
Nrg1-ErbB signalling pathway (Supplementary Fig. 7 and
Supplementary Table 1), and determined how this correl-
ates with remyelination after spinal cord injury. In particu-
lar, we assessed expression of Nrg1 isoforms types I and II
(containing Ig-like domains) and type III (containing a cyst-
eine-rich domain). Nrg1 type I expression within the spinal
cord progressively increased at Weeks 1 and 4 post-injury
(Supplementary Fig. 7A). In contrast, Nrg1 type II and type
III expression had signiﬁcantly decreased at 1 week post-
injury, and recovered to 50% of the naı¨ve levels 4 weeks
post-injury (Supplementary Fig. 7A). These changes in
Nrg1 isoform expression after injury were restricted to
the spinal cord and not observed in peripheral dorsal
root ganglia, where Nrg1 types I and II were unchanged
and type III showed only a small transient decrease
(Supplementary Fig. 8). Typically, Nrg1 exerts its effects
via interaction with ErbB tyrosine kinase receptors
(Birchmeier and Nave, 2008; Mei and Nave, 2014).
Expression of ErbB3 and ErbB4 in the spinal cord followed
a similar pattern to that of Nrg1 types II and III, and was
signiﬁcantly reduced at 1 week post-injury, with a subse-
quent partial recovery (Supplementary Fig. 7B). ErbB2 ex-
pression was increased at 4 weeks post-injury
(Supplementary Fig. 7B). Thus, changes in expression of
Nrg1 signalling components after injury appear to be
consistent with the timing of Schwann cell-mediated remye-
lination in the spinal cord. Thus, when P0-positive
Schwann cell-derived myelin is abundant in the dorsal
columns (at 4 weeks, but not 1 week, post-injury;
Fig. 5A–F) the expression of type III Nrg1 and ErbB3/4
has recovered and the expression of type I Nrg1 and
erbB2 has increased.
The majority of Schwann cells that
remyelinate injured spinal axons have
a CNS origin
The origin of remyelinating Schwann cells in CNS patholo-
gies has been debated. To investigate the origin of the remye-
linating Schwann cells after spinal cord injury, we removed
peripheral input into the spinal cord with bilateral removal
of multiple dorsal roots directly adjacent and feeding into
the injury site. We used rats, rather than mice for these
studies, due to the complexity of the surgery, after ﬁrst
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determining that the time course of Schwann cell-mediated
remyelination in the dorsal columns was the same in both
species (Fig. 5A–F and James et al., 2011). Efﬁcient removal
of the entire dorsal root and dorsal root entry zone was
conﬁrmed by the presence of a GFAP-positive astrocytic
‘cap’ on the avulsed root (Fig. 5H’’). No matter whether
the roots were intact or removed, Schwann cell-derived
myelin was apparent in the injured dorsal columns (Fig.
Figure 2 Ultrastructural analysis of Schwann cell-mediated remyelination of spinal axons after injury and its dependence on Nrg1
signalling. (A–C) Electron micrographs of transverse sections of the dorsal column 10 weeks after spinal contusion injury in vehicle control (Vh control;
A), tamoxifen control (Tx control; B) and conditional Nrg1 mutant (conNrg1; C) mice. In control animals, axons are undergoing remyelination and
Schwann cells (white asterisk) can be seen to mediate remyelination; Schwann cells and their myelin are identified by the signet ring-like appearance of
Schwann cell myelin, thicker and more compact myelin, and basal laminae around the Schwann cells. In conNrg1 mutant animals, many large diameter
unmyelinated axons are visible (black asterisk), Schwann cells were rarely detected and the small degree of remyelination is mediated by oligodendrocytes
that produce a thin myelin sheath (arrows). Remyelinating oligodendrocytes do not have nuclei directly apposed to the myelin or surrounding basal lamina
and oligodendrocyte-associated myelin is less dense than the myelin associated with Schwann cells. (D) The number of myelinated axons in the
dorsal column was significantly decreased in conNrg1 mice compared with control (Vh control = 998  160, Tx control = 1132  256 and
conNrg1 = 134  20). (E) The percentage of unmyelinated axons with a diameter41 mm was increased in conNrg1 animals versus control (Vh
control = 8%  2, Tx control = 5%  2 and conNrg1 = 26%  8). (F) A dramatic reduction in the number of Scwann cell-myelinated axons in conNrg1
mutant animals was observed (Vh control = 522  192, Tx control = 794  227 and conNrg1 = 17  16). (G) A significant increase in the G-ratio in the
conNrg1 animals (Vh control = 0.72  0.01, Tx control = 0.71  0.02 and conNrg1 = 0.81  0.02) indicate very thin myelin sheaths. Data shown in D–
G are presented as mean  SEM. (P5 0.05, one-way ANOVA, post hoc Tukey’s n = 3–4 animals/group). No significant differences were observed
between the two control groups in any of the measures analysed. Scale bar = 2 mm. (H) Scatter plot relating G-ratio and axon diameter of all the axons
analysed show a shift to higher G-ratios in conNrg1 animals (P5 0.001 Kolmogorov-Smirnov test) without significant changes in axon calibre. (I)
Comparison of counts of total myelinated axons and axons myelinated by oligodendrocytes in vehicle control, tamoxifen control and conNrg1 animals.
After ablation of Nrg1 the total number of myelinated axons is decreased (data are presented as mean  SEM, P5 0.05, one-way ANOVA, post hoc
Tukey’s, n = 3–4 animals/group) but the number of axons myelinated by oligodendrocytes is not altered (Vh control = 475  326, Tx con-
trol = 338  184 and conNrg1 = 117  60). (J) The total number of axons present in the dorsal column after spinal cord contusion remains similar in all
groups (data are presented as mean  SEM, one-way ANOVA, post hoc Tukey’s, n = 3–4 animals/group).
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5G and H). Quantiﬁcation revealed a small reduction in the
amount of P0 myelin in the dorsal columns after multiple
root avulsion, although this did not reach signiﬁcance
(Supplementary Fig. 9), indicating that the majority of the
Schwann cell myelin in the dorsal columns derives from a
central source, but at least some of the remyelinating
Schwann cells may be peripherally derived. Alternatively,
the amount of Schwann cell-mediated central remyelination
may have been altered by changes in astrogliosis following
multiple dorsal root removal, in line with recent ﬁndings
(Monteiro de Castro et al., 2015).
To further determine whether remyelinating Schwann
cells originate from a central source, we administered
EdU to mice following spinal contusion and assessed for
the presence of newly dividing cells in the spinal cord at 4
weeks post-injury (a time point when myelinating Schwann
cells are present in the dorsal columns; Fig. 5C and F). Co-
localization of EdU with P0 in spinal sections from these
animals (Fig. 6) revealed numerous EdU-positive cells dir-
ectly adjacent to P0-positive Schwann cell myelin rings
(Fig. 6B and C), providing evidence that myelinating
Schwann cells were newly generated endogenous precursor
cells. We observed a striking comparison between the histo-
logical observations of EdU positive nuclei in close appos-
ition to P0-positive Schwann cell myelin (Fig 6C’) and the
electron microscopy observations of a one-to-one relation-
ship of a Schwann cell remyelinating a central axon in the
dorsal columns (Fig 6C’’). Co-localization of EdU with PLP
revealed far fewer oligodendrocyte-derived myelin rings in
the injured dorsal columns (Fig. 6D).
These data provide evidence that peripherally invading
Schwann cells do not play a signiﬁcant role in remyelina-
tion of spinal axons after spinal cord injury. Rather, the
majority of these remyelinating Schwann cells derive from a
CNS origin and are the major contributor to this endogen-
ous repair mechanism. Our results suggest that Nrg1 is the
molecular switch that drives precursor cells residing in the
spinal cord to differentiate into PNS-like Schwann cells and
to remyelinate spinal axons.
Figure 3 Nrg1-dependent central axon remyelination after spinal cord injury is mediated by typical Schwann cells. (A–F)
Co-staining of basal lamina (laminin, red) and Schwann cell-associated myelin (P0, green) in tamoxifen control (Tx control, A–C) and Nrg1-
ablated (conNrg1, D–F) mouse spinal cords 10 weeks after contusion injury reveals defined ring-like structures immunoreactive for laminin.
These ring-like structures represent the typical basal lamina associated with Schwann cells, and are apparent in close proximity to P0-positive
myelin rings in injured control spinal cord. No Schwann cell-associated myelin and only sparse and diffuse laminin staining is observed in
spinal cords from conNrg1 mice. Scale bar = 25 mm. Images not using the red/green colour scheme are available in the Supplementary
material.
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Figure 4 Expression of Nrg1 before and after spinal cord injury. Fluorescent in situ hybridization using a pan-Nrg1 probe (red) co-stained
with markers for neurons (NeuN, blue), Schwann cell associated myelin (P0, green, A, C, E, G) and oligodendrocytes (Olig2, green, B, D, F and H).
In the uninjured spinal cord (A–D) Nrg1 labelling can be seen within neurons. The highest level of expression is seen in motor neurons within the
ventral horn; however Nrg1 is also expressed by neurons of the dorsal horn. In the uninjured state there is no co-localization of Nrg with P0 (A and
C) and very few oligodendrocytes express Nrg1 (B and D). Four weeks after spinal contusion injury, compact myelin, which is P0 immunoreactive,
can be seen within the dorsal column and there is little co-localization with Nrg1 (E and G). Similarly, few Olig2 immunoreactive profiles express
Nrg1 (F and H). Scale bars = 250 mm (B); 100 mm (H). Images not using the red/green colour scheme are available in the Supplementary material.
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Immunoglobulin-containing isoforms
of Nrg1 are dispensable for Schwann
cell remyelination
Given the complex changes in Nrg1 isoform expression after
spinal cord injury, we used isoform-speciﬁc mutant mice to
distinguish functions of particular Nrg1 isoforms in spinal
axon remyelination and recovery of locomotor function. To
do this we used a strain of mice in which Ig domain-contain-
ing Nrg1 isoforms (Nrg1 types I and II) are ablated after tam-
oxifen treatment (conIgNrg1 mice), but the type III Nrg1
isoform remains intact (Cheret et al., 2013). We ﬁrst con-
ﬁrmed that after tamoxifen treatment, levels of IgNrg1 tran-
scripts in the thoracic spinal cord and in dorsal root ganglia
were signiﬁcantly reduced when compared to tamoxifen-trea-
ted control littermates not expressing Cre (Supplementary
Fig. 10A and B). Expression of type III Nrg1 was unchanged
(Supplementary Fig. 10C and D). To analyse remyelination in
these animals, we assessed the expression of Schwann cell-
derived myelin throughout the lesion site after injury. P0
immunohistochemistry at 10 weeks after contusive spinal
cord injury revealed that Schwann cell-mediated axonal
remyelination is indistinguishable between tamoxifen-treated
control and conIgNrg1 animals, with a similar rostrocaudal
spread of P0 expression observed in the dorsal column (Fig.
7A–C). Schwann cell-associated myelin was most abundant
at the lesion epicentre where60% of the dorsal column area
expressed peripheral myelin (Fig. 7C). This is therefore in
stark contrast to conNrg1 animals in which all Nrg1 isoforms
are ablated and suggests that type I and II isoforms (contain-
ing the Ig domain) are dispensable for central remyelination
after spinal cord injury. Thus, the presence of the type III
Nrg1 isoform sufﬁces to trigger the remyelination process.
Conditional ablation of Nrg1 has a
significant impact on the level of
spontaneous locomotor recovery
after spinal cord injury
To evaluate the functional consequences of Nrg1 ablation
we ﬁrst assessed gross locomotor function in conNrg1 and
conIgNrg1 mice using the BMS open ﬁeld hindlimb
Figure 5 Schwann cell-mediated remyelination in mouse and rat spinal cords follows the same time course and is unhindered
by avulsion of multiple dorsal roots at and adjacent to the injury site. (A–C) Co-staining of astrocytes (GFAP, red) and Schwann cell-
associated myelin (P0, green), shows the time course of the appearance of Schwann cell myelin the injured mouse spinal course. Peripheral myelin
(P0) is not apparent in uninjured mouse spinal cord (A) or at 1 week post-injury (B), but is present in the dorsal columns by 4 weeks after injury
(C). C’ shows a high magnification of the boxed area in panel C. (D–F) Co-staining of astrocytes (GFAP, red) and Schwann cell-associated myelin
(P0, green), shows the time course of the appearance of Schwann cell myelin the injured rat spinal course. Peripheral myelin (P0) is not apparent in
uninjured rat spinal cord (D) or at 1 week post-injury (E), but is present by 4 weeks after injury (F). F’ shows high magnification of the boxed area
in panel F. (G and H) At 10 weeks post-injury Schwann cell-mediated remyelination is apparent after spinal contusion injury irrespective of
presence (G) or absence (H) of dorsal roots, one of the main possible peripheral sources of the Schwann cells. G’ and H’ show high magni-
fications of boxed areas in panels G and H. (H’’) Example of an avulsed dorsal root, which encompasses the entire rootlet including the dorsal
root entry zone that is visualized by staining of the astroglial marker GFAP. Scale bars = 250 mm (A and D); 50 mm (C’ and F’). Images not using
the red/green colour scheme are available in the Supplementary material.
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Figure 6 Centrally remyelinating Schwann cells are produced de novo in the injured spinal cord. (A and B) Immunohistochemical
staining for Schwann cell myelin (P0, green), nuclear EdU (red) and DAPI (blue) shows abundant P0-positive myelin rings in close apposition with
EdU-positive cell nuclei 4 weeks after contusion injury (B) but not in control uninjured spinal cords (A). (C) High magnification image showing the
boxed area in B, demonstrating remyelinating EdU-positive Schwann cells in association with P0-positive Schwann cell-derived myelin. (D) High
magnification image of dorsal column axons associated with central PLP-positive myelin. (C’ and C’’) High magnification image showing the boxed
area in C. Co-labelling clearly reveals direct apposition of a EdU-positive Schwann cell with a P0-positive myelin ring (C’) alongside an electron
microscopic comparison of a Schwann cell in the dorsal columns that has remyelinated a CNS axon (C’’). Scale bars = 100 mm (B); 20 mm (D); 2
mm (C’). Images not using the red/green colour scheme are available in the Supplementary material.
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locomotor scale (Fig. 8A–D; BMS behaviour displayed sep-
arately as these were separate studies). In the conNrg1
study (Fig. 8A and B), no differences in baseline BMS rat-
ings were detected in uninjured animals, regardless of
whether Nrg1 was present or ablated. However, following
spinal cord contusion Nrg1 ablation was associated with
signiﬁcant long-term impaired locomotor recovery (Fig. 8A
and Supplementary Videos 1 and 2). Furthermore, we
observed impaired paw rotation and forelimb-hindlimb co-
ordination post-injury in conNrg1 mice compared to con-
trol mice, i.e. processes that require proprioceptive control
mediated by dorsal column axons (Kanagal and Muir,
2008). However, it should be noted that the impact of
Nrg1 ablation on spontaneous locomotor recovery started
to emerge during the ﬁrst 2 weeks after injury, a time
where signiﬁcant remyelination in the dorsal columns is
not yet apparent following spinal contusion injury (James
et al., 2011). Therefore, in addition to the deﬁcient
remyelination, other mechanisms might also contribute to
the changed locomotor recovery, such as deﬁcient muscle
spindle feedback, which has recently been shown to be im-
portant for locomotor recovery after spinal cord injury
(Takeoka et al., 2014). Indeed, Nrg1 is an important
signal for muscle spindle maintenance and muscle spindles
atrophy after Nrg1 ablation in the adult (Cheret et al.,
2013). We then assessed BMS scores in conIgNrg1 mice
(Fig. 8C and D), where Schwann cell-mediated remyelina-
tion remains intact. Interestingly, in spite of preserved
spontaneous remyelination, locomotor recovery was also
impaired in conIgNrg1 mice compared to control injured
animals (Fig. 8C). In general, animals showed impairments
in coordination similar to, but not as extensive as, the ani-
mals lacking all Nrg1 isoforms (cf. Fig. 8A and C).
To further elucidate the contribution of Nrg1 to func-
tional repair after spinal cord injury, we performed add-
itional functional studies in new cohorts of conNrg1 and
Figure 7 Ablation of Ig-containing isoforms of Nrg1 (Nrg1 types 1 and 2) does not interfere with Schwann cell-mediated
remyelination after spinal contusion injury. (A and B) Co-staining of astrocytes (GFAP, red) and Schwann cell-associated myelin (P0, green)
shows appearance of Schwann cell myelin the injured mouse spinal cord of tamoxifen control (Tx control, A) and IgNrg1-ablated mice
(conIgNrg1, B). Ten weeks after contusion injury, Schwann cell-associated myelin (P0) is abundant in the dorsal column of spinal cords from both
control animals and mice lacking the IgNrg1 isoforms, being particularly abundant in the lesion epicentre. (A’ and B’) High magnification of boxed
areas in A and B. (C) Quantification of P0-positive area in sections spanning the rostrocaudal axis of the injury site reveals similar levels in
conIgNrg1 and control mice (nsP4 0.05, two-way ANOVA, post hoc Bonferroni, n = 4 animals/group). Scale bars = 250 mm (B); 50 mm (B’).
Images not using the red/green colour scheme are available in the Supplementary material.
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Figure 8 Ablation of Nrg1 leads to impaired spontaneous functional recovery after spinal contusion injury. Functional recovery
assessed by BMS open field locomotion scores in conNrg1 (A) and conIgNrg1 (C) mice show a similar initial deficit in all groups acutely after
spinal contusion injury. BMS scores gradually improve over the first few weeks and begin to plateau 3 weeks post-injury. Spontaneous functional
recovery is significantly impaired in both conNrg1 (A) and conIgNrg1 (C) mutant mice, compared to vehicle and tamoxifen controls. Baseline
(Continued)
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conIgNrg1 mice to enable side-by-side comparisons in a
number of additional behavioural outcomes (Fig. 8E and
F). The 12-point BMS subscore scale, which further delin-
eates recovery of speciﬁc locomotor features that may not
be apparent in the overall BMS score (Basso et al., 2006),
revealed that while both cohorts were signiﬁcantly impaired
in comparison to control injured mice, the conNrg1 mice
were also signiﬁcantly worse than conIgNrg1mice at 8
weeks post-injury (#P5 0.05, conNrg1 versus conIgNrg1;
average score 0.4  0.26 and 3  0.65, respectively; Fig.
8E) on aspects of behaviour related to stepping frequency,
coordination, paw position, trunk stability, and tail pos-
ition. Furthermore, functional performance was also as-
sessed on the beam walking task, which requires co-
ordination, balance and proprioception (functions that are
directly related to dorsal column function; Kanagal and
Muir, 2008). Again, conNrg1 mice performed signiﬁcantly
worse than injured conIgNrg1mice on the beam walking
task (#P5 0.05, conNrg1 versus conIgNrg1; average
score 14  3.7 and 33  1.5, respectively; Fig. 8F). These
data clearly demonstrate that there was signiﬁcantly worse
functional outcome in conNrg1 mice (with the profound
dorsal column demyelinating phenotype) than in
conIgNrg1 mice (where Schwann cell-mediated remyelina-
tion was not altered), particularly in tasks that require
dorsal column function.
Conditional ablation of Nrg1 leads to
conduction failure in dorsal column
axons after spinal cord injury
Although behavioural differences suggest an association be-
tween the profound demyelinating phenotype in conNrg1
mice and worse functional outcome, a more robust measure
for determining the functional importance of Schwann cell-
mediated remyelination after spinal cord injury and how
this is compromised by Nrg1 ablation is to assess the elec-
trophysiological properties of dorsal column axons in con-
trol and Nrg1 mutant mice following spinal contusion. In a
protocol adapted from a previous method in rats (James et
al., 2011), terminal electrophysiological recordings taken
from the sural nerve revealed a clear difference in the abil-
ity of long distance sensory ﬁbres travelling in the dorsal
columns to conduct through the T10 spinal contusion site
(Fig. 8G). Sensory dorsal column ﬁbres were activated anti-
dromically by ﬁrstly stimulating 5mm caudal of the lesion
site. Recordings taken from the sural nerve whilst stimulat-
ing supramaximally therefore represented the function of
the intact portion of this pathway. Stimulation was then
moved 5mm rostral of the lesion site to determine what
extent of this function remained through the lesion site.
Recordings taken when stimulating at each site were aver-
aged and the amplitude of the response in the sural nerve
when stimulating rostral to the lesion was calculated as a
percentage of the response evoked when stimulating caud-
ally. In both of the tamoxifen control cohorts and the con
IgNrg1 cohort, all animals displayed obvious evoked activ-
ity in the sural nerve when stimulating rostrally; in contrast
to this, the majority of conNrg1 animals (four of ﬁve) dis-
played no detectable evoked activity in the sural nerve, and
in the single animal which displayed some activity this was
minimal (representative traces in Fig. 8G). Quantiﬁcation
revealed that this difference in the conduction of dorsal
column ﬁbres was highly signiﬁcant (graph in Fig. 8G;
P5 0.01, #P5 0.05, one-way ANOVA, Tukey’s post
hoc), with the conNrg1 group having a mean conduction
of only 5.05%  1.03 and all other groups having conduc-
tion of 25% (conNrg1 tamoxifen control: 25.27% 
3.42; IgNrg1 tamoxifen control: 23.26%  3.96;
conIgNrg1: 23.45%  3.77). These data provide robust in
vivo evidence ﬁrstly, that dorsal column axons remyeli-
nated by Schwann cells after spinal cord injury are func-
tional and secondly, that the profound demyelinating
Figure 8 Continued
BMS scores were not different between groups. Data are presented as mean  SEM. (P5 0.001, two-way ANOVA, post hoc Bonferroni, n = 9–
11 animals/group). (B and D) Contusion impact data showing the actual force applied to individual mice was within 10% of the intended force of
50 kdyne and mean values for each group were not significantly different (P4 0.05; one-way ANOVA), confirming that any group differences were
not due to differences in the impact force during surgery. (E) BMS subscores reveal significantly reduced functional recovery both in conNrg1 and
conIgNrg1 animals compared to controls at 8 weeks post-injury. However, conNrg1 mice were significantly more impaired than conIgNrg1 mice
in areas including stepping frequency, coordination, paw position, trunk stability, and tail position. (F) Beam-walking scores reveal reduced beam-
walking performance both in conNrg1 and conIgNrg1 animals compared to controls at 8 weeks post-injury. However, conNrg1 mice were
significantly more impaired than conIgNrg1 mice. Data are presented as mean  SEM (P5 0.01, #P5 0.05, one-way ANOVA, post hoc Tukey’s,
n = 6–9 animals/group). Significantly different to tamoxifen controls; #significantly different to conIgNrg1. (G) In vivo electrophysiological
recordings assessing dorsal column function. Example traces (each averaged from 16 raw traces) show conduction through the lesion site in
control, conNrg1 and conIgNrg1 animals (the representative control trace is taken from a conNrg1 tamoxifen control mouse). In control and
conIgNrg1 injured animals stimulation artefacts, which have been cropped on the x-axis to allow appropriate scaling, were followed by evoked
afferent activity at a latency of 1.5 ms, whereas little or no activity was evoked in conNrg1 animals. All stimulation was supramaximal.
Quantification of the percentage of axons capable of conducting through the contusion site confirmed significant levels of dorsal column function
in injured controls and conIgNrg1 mice at 10 weeks post-injury (when significant Schwann cell-mediated remyelination of the dorsal columns is
apparent), which was dramatically reduced in conNrg1 animals (where Schwann cell-mediated remyelination is absent). Data are presented as
mean  SEM (P5 0.01, #P5 0.05, one-way ANOVA, post hoc Tukey’s, n = 5–6 animals/group); significantly different to tamoxifen controls;
#significantly different to conIgNrg1.
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phenotype observed in the dorsal columns of conNrg1
knockout mice, and the associated functional impairment,
corresponds to axonal conduction failure.
Discussion
Our data show that Nrg1 is a key regulator of remyelina-
tion of CNS axons by PNS-like Schwann cells after spinal
cord injury. The majority of these centrally occurring
Schwann cells are derived from the CNS, and arise most
likely through (trans)-differentiation of precursor cells that
reside in the spinal cord. Furthermore, we show that inter-
ference with Nrg1 signalling signiﬁcantly reduces the degree
of spontaneous locomotor recovery after injury. Using
Nrg1 isoform-speciﬁc mutant mice, we found that IgNrg1
isoforms are dispensable for Schwann cell myelination,
indicating that type III (cysteine-rich domain containing)
isoforms have a critical role in this repair process.
Although IgNrg1 isoforms do not mediate Schwann cell
remyelination, they contribute to recovery of locomotor
function. We assign this to the role of IgNrg1 in muscle
spindle maintenance. The functional impairment in those
animals in which all Nrg1 isoforms are inactivated is
greater than in the IgNrg1 speciﬁc mutants, particularly
in measures relating to dorsal column function correspond-
ing with profound conduction block observed on electro-
physiological assessment of sensory axons projecting
through the injury site within the dorsal column. Our
data emphasize the distinct roles of Nrg1 isoforms in in-
trinsic repair processes after traumatic spinal cord injury.
Manipulating Nrg1 signalling might thus lead to novel
therapeutic strategies, or form part of a combinatorial ther-
apy, for enhancing repair after spinal cord injury.
The injured CNS has some intrinsic capacity to spontan-
eously repair. Understanding the mechanisms that regulate
or restrict these natural regenerative processes may lead to
novel clinical paradigms that enhance spontaneous recovery
after spinal cord injury or augment the efﬁcacy of existing
therapeutic approaches. Experimental contusive spinal cord
injury resembles many human spinal cord injuries (Bunge et
al., 1993; Kakulas, 1999; Norenberg et al., 2004). An im-
portant feature of contusion-type injuries is the sparing of a
peripheral rim of tissue that contains viable axons.
Demyelination is a key pathological characteristic of surviv-
ing axons that limit their ability to function properly, as
these focally demyelinated axons are unable to efﬁciently
conduct action potentials (Koles and Rasminsky, 1972;
Nashmi and Fehlings, 2001). These surviving axons
remain non-functional but represent an important thera-
peutic target (James et al., 2011). Remyelination and res-
toration of conduction may lead to detectable functional
improvement (Smith et al., 1979; Waxman et al., 1994).
Robust spontaneous myelin repair can occur, which is
mediated by both immature oligodendrocytes and
Schwann cells (Harrison et al., 1975; McDonald, 1975).
Schwann cell-mediated remyelination in the CNS has been
reported after spinal cord injury in many species including
rodents (Beattie et al., 1997; James et al., 2011), cats
(Bunge et al., 1961; Blight and Young, 1989), monkeys
(Bresnahan, 1978) and humans (Bunge et al., 1993; Bruce
et al., 2000; Guest et al., 2005). It has also been observed
in other central pathologies such as multiple sclerosis
(Ghatak et al., 1973; Itoyama et al., 1985) and compressive
spondylotic myelopathy (Fehlings and Skaf, 1998).
Moreover, central axons that are remyelinated by
Schwann cells can regain function (Blight and Young,
1989). Thus, the phenomenon of Schwann cell-mediated
remyelination of central axons is well known, but the mo-
lecular mechanism of this spontaneous regenerative event
has remained obscure. We now show for the ﬁrst time that
a lack of Nrg1 entirely prevents remyelination of spinal
axons by PNS-like Schwann cells after spinal cord injury.
We observed abundant peripheral myelin in the dorsal col-
umns of the injured spinal cord, which was completely
absent when Nrg1 is lacking. This striking phenotype was
conﬁrmed by detailed ultrastructural analysis, which
demonstrated a complete lack of PNS-like Schwann cells
in the central dorsal columns accompanied by remyelina-
tion failure. Oligodendrocytes, which myelinate different
calibre axons in the mammalian CNS, are heterogenous.
Type IV oligodendrocytes morphologically resemble
Schwann cells that myelinate PNS axons but lack the char-
acteristic basal laminae of Schwann cells (Cornbrooks et
al., 1983; Butt et al., 1995). We observed clear laminin
immunoreactivity surrounding P0-positive myelin rings in
the injured spinal cord, demonstrating that the cells respon-
sible for remyelination contain a basal lamina. Thus,
remyelinating cells are typical Schwann cells rather than
type IV oligodendrocytes. This ring-like association of lam-
inin-positive basal lamina with Schwann cell derived P0-
positive myelin was entirely absent in mice lacking Nrg1,
which is consistent with the absence of Schwann cells.
However, diffuse laminin staining was still observed in
the injured spinal cord from Nrg1-ablated animals, which
is likely to be derived from other cells present at the injury
site such as ﬁbroblasts or vascular components (Elkhal et
al., 2004; Soderblom et al., 2013).
In a number of other CNS disorders (such as stroke),
Nrg1 has been shown to have neuroprotective effects
(Croslan et al., 2008; Iaci et al., 2010). Therefore we per-
formed axonal counts in the dorsal columns to determine
the effects of Nrg1 on axonal survival after spinal cord
injury. Although we observed no differences between
injured controls and conNrg1 mice in the total number of
surviving axons 10 weeks after spinal cord injury, it is
conceivable that axons that remain persistently demyeli-
nated in Nrg1-ablated animals would be more susceptible
to axonal loss and degeneration at later time points and
this would likely exacerbate functional impairment, as has
been observed in other CNS pathologies (Bjartmar et al.,
2000; Lovas et al., 2000; McGavern et al., 2000; Lee et al.,
2012).
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Despite signiﬁcant spontaneous remyelination, some
axons remain chronically demyelinated after spinal cord
injury (Blight and Decrescito, 1986; Waxman, 1989;
Bunge et al., 1993; Crowe et al., 1997; Guest et al.,
2005). Recent work showed that the time course of demye-
lination and remyelination corresponded to functional
changes, and demonstrated that a population of chronically
demyelinated axons retain the potential to conduct (James
et al., 2011). Our data conﬁrm that demyelinated axons
persist into the chronic period after contusive injury, but
a large population of axons are robustly remyelinated by
PNS-like Schwann cells. The importance of such remyelina-
tion is emphasized by the profound conduction failure in
sensory axons projecting through the dorsal columns in
conNrg1 mice. Our ﬁndings also highlight the poor cap-
acity of oligodendrocytes to mediate remyelination after
spinal cord injury. In the presence or absence of Nrg1,
only a few axons were surrounded by abnormally thin
oligodendrocyte-produced myelin. The lack of compensa-
tory remyelination by oligodendrocytes in Nrg1-ablated
mice was also evident by the unchanged expression of
PLP-positive central myelin and the oligodendrocyte-speciﬁc
transcription factor Olig2 at time points when axons are
normally robustly remyelinated by Schwann cells
(Brinkmann et al., 2008; Makinodan et al., 2012). Nrg1
ablation might have potentially inﬂuenced oligodendrocyte-
mediated remyelination. However, our analysis presented
here, as well as previous work, indicates that oligodendro-
cyte-mediated myelination/remyelination is not absolutely
dependent on Nrg1 (Brinkmann et al., 2008; Lundgaard
et al., 2013). Schwann cell remyelination of central axons
after injury appears to be limited to the dorsal column
region of the spinal cord, as we observed here, while
other lateral and ventral white matter tracts remain persist-
ently demyelinated, or are remyelinated predominantly by
oligodendrocytes derived from precursor cells (Siegenthaler
et al., 2007). Here we focused on the effects of Nrg1 on
demyelination and remyelination in the dorsal column. It
remains to be seen whether Nrg1 also affects remyelination
in other white matter tracts, and whether increasing Nrg1
expression could increase remyelination in other regions of
the spinal cord.
The cues that govern the occurrence of endogenous
PNS-like Schwann cells in the injured CNS are unknown.
Schwann cells have been suggested to migrate from per-
ipheral sources such as the dorsal roots into the spinal
cord after an injury (Sims et al., 1998; Jasmin et al.,
2000; Perlin et al., 2011), or to originate from endogenous
oligodendrocyte precursor cells in the spinal cord
(Zawadzka et al., 2010). The predominant localization
of remyelinating Schwann cells in the dorsal columns,
close to the dorsal root entry zone PNS/CNS interface,
logically favours a peripheral source. However, here we
demonstrate for the ﬁrst time that removing the peripheral
source of Schwann cells by multiple dorsal root removal
had little impact on Schwann cell-mediated remyelination
of dorsal column axons. The small reduction in P0
following multiple root removal indicates that a minor
proportion of the remyelinating Schwann cells may
derive from the periphery. However, as the majority of
P0 myelin expression still remained in the dorsal columns
after removal of peripheral input, this supports the notion
that the majority of these remyelinating Schwann cells
derive from the spinal cord, possibly from spinal cord-
intrinsic progenitor populations. A potential mechanism
is a spontaneous, injury induced (trans)-differentiation of
endogenous oligodendrocyte precursors into Schwann
cells, which is consistent with evidence obtained in
models of focal demyelination, where fate mapping of pro-
genitor cells in the adult spinal cord revealed a previously
unappreciated capacity of CNS precursors to generate
myelinating Schwann cells (Zawadzka et al., 2010). Our
data demonstrate that this phenomenon also occurs after
traumatic spinal cord injury, with the observation of EdU
and P0 co-expression providing direct evidence that mye-
linating Schwann cells in the contused spinal cord were
newly generated cells. This is also in line with recent lin-
eage tracing studies, which used genetic reporters of en-
dogenous precursor cells to demonstrate that remyelinating
Schwann cells after spinal contusion are primarily central
in origin (Assinck et al., 2015). Together, these ﬁndings
provide strong evidence for a central origin of remyelinat-
ing Schwann cells following clinically relevant traumatic
spinal contusion injury.
Concomitantly with the initiation of Schwann cell-
mediated remyelination of dorsal column axons, we noted
complex changes in expression of Nrg1 isoforms and their
receptors. Analysis of isoform-speciﬁc mRNA expression
showed parallels to the changes observed within peripheral
nerve following injury. In particular, type I Nrg1 was upre-
gulated (Cohen et al., 1992; Carroll et al., 1997; Stassart et
al., 2013) and the expression of type II and III Nrg1 iso-
forms were reduced 1 week after injury, but expression
began to recover towards naı¨ve levels 4 weeks after
injury. Lumbar dorsal root ganglia (containing the cell
bodies of dorsal column projecting axons) did not display
major changes in Nrg1 isoform expression. Erbb3 and
Erbb4 receptor mRNA within the spinal cord was reduced
at Week 1 but largely recovered by Week 4 post-injury;
Erbb2 showed increased expression at Week 4 post-
injury. Given that many cell types including neurons, glia
(Mei and Nave, 2014) and immune cells (Calvo et al.,
2010) express these receptors, this dynamic pattern of ex-
pression is likely to reﬂect in addition to altered expression
in individual cells the changed cellular composition that is
inﬂuenced by cell death, acute inﬂammation and subse-
quent endogenous repair following spinal cord injury. In
general, by 4 weeks post-injury the expression of Nrg1
signalling components is replenished or enhanced, and
this coincides with progressive remyelination of demyeli-
nated axons by Schwann cells in the injured spinal cord.
Our in situ hybridization expression data indicated that the
main source of Nrg1 inﬂuencing Schwann cell remyelina-
tion after spinal cord injury is likely to be derived from
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spinal neurons or axons projecting through the dorsal
column, as Nrg1 was apparent in the dorsal columns but
did not co-localize with markers of Schwann cell myelin or
oligodendrocytes. This is consistent with previous work
which has shown high levels of expression of Nrg1 (par-
ticularly type III Nrg1) in the large diameter myelinated
sensory neurons (Bermingham-McDonogh et al., 1997;
Fricker et al., 2009), whose axons project in the dorsal
column.
Nrg1 isoforms signal in distinct fashions: Types I and II
(containing Ig domains) are directly secreted or shed from
the cell membrane while type III (containing a cysteine rich
domain) typically remains tethered to the cell membrane to
signal in a juxtacrine fashion, although further processing
can release the EGF domain in certain contexts (Fleck et al.,
2013). In the PNS, type III Nrg1 is the key factor that
regulates many aspects of Schwann cell development and
function, including myelination, which is absolutely de-
pendent on type III Nrg1 (Garratt et al., 2000; Nave and
Salzer, 2006; Mei and Nave, 2014). In contrast, although
both type I and type III Nrg1 isoforms have been shown to
inﬂuence central myelination, oligodendrocytes (unlike per-
ipheral Schwann cells) have evolved a Nrg1-independent
mechanism of myelination (Brinkmann et al., 2008; Nave
and Werner, 2014). Interestingly after peripheral nerve
injury in adulthood there is evidence that both axonal
(which is principally type III Nrg1) (Fricker et al., 2011)
and Schwann cell-derived type I Nrg1 contribute to
Schwann cell remyelination (Stassart et al., 2013). In con-
trast, we did not observe Nrg1 expression by Schwann cells
within the injured spinal cord. We have taken advantage of
isoform-speciﬁc mutant mice to investigate the relative con-
tribution of the different isoforms in adulthood after CNS
injury. Schwann cell-mediated remyelination of the dorsal
columns was absent in mice lacking all active Nrg1 iso-
forms, while the lack of only IgNrg1 isoforms did not inter-
fere with Schwann cell-mediated remyelination,
emphasizing the role of type III Nrg1 in this repair process.
The fact that IgNrg1 is dispensable for Schwann cell remye-
lination in the spinal cord is consistent with the previous
ﬁnding that infusion of glial growth factor (Ig containing
type II Nrg1 isoform) did not improve Schwann cell-
mediated remyelination after a gliotoxic injury to the cere-
bellar peduncle (Penderis et al., 2003). Unexpectedly, how-
ever, spontaneous locomotor recovery was signiﬁcantly
compromised irrespective of the presence or absence of
type III Nrg1. This indicates that the functional deﬁcits
were not entirely due to the striking demyelination
phenotype observed in mice lacking all Nrg1 isoforms.
The importance of Ig-containing Nrg1 in the regulation
of muscle spindle development and physiology has previ-
ously been demonstrated (Hippenmeyer et al., 2002; Cheret
et al., 2013). Thus, the behavioural phenotype observed in
our study may involve deﬁcient muscle spindle-dependent
sensory feedback to the spinal cord, which has recently
been shown to be critical for basic locomotor recovery
after spinal cord injury (Takeoka et al., 2014).
However, to elucidate further the contribution of dorsal
column demyelination to the locomotor deﬁcits, we per-
formed further detailed functional assessments in additional
cohorts of animals. We directly compared functional recov-
ery in conNrg1 mice (in which all Nrg1 isoforms are inac-
tivated) and in conIgNrg1 animals in which there is
selective inactivation of Ig isoforms. Although both mutants
showed functional deﬁcits, these were most marked in the
conNrg1 compared to conIgNrg1, emphasizing the role of
Schwann cell remyelination within the dorsal column for
optimal recovery. This was apparent both on the BMS
subscale and the inclined beam walking task, which re-
quires co-ordination, balance and proprioception—
functions that relate to the dorsal column pathway,
through which myelinated proprioceptive sensory afferents
transit. To directly localize this deﬁcit to the dorsal column
we undertook electrophysiological assessment by anti-
dromic stimulation of sural afferents (which are principally
sensory) within the dorsal column rostral and caudal to the
injury site. While afferents projecting through the injury
site could be detected in control animals (the evoked
compound sensory action potential recorded in the sural
nerve following rostral stimulation was 25% of that
following caudal stimulation) there was a profound deﬁcit
in conduction in the conNrg1 mice (which in most cases
showed no conduction through the injury site). In contrast,
the conIgNrg1 mice demonstrated impulse conduction
which was no different to controls, consistent with the
fact that Schwann cell remyelination was unchanged in
these animals.
In summary, our data demonstrate that Nrg1 is abso-
lutely essential for Schwann cell-mediated spinal axon
remyelination following spinal cord injury. We provide evi-
dence that these central Schwann cells derive from the
injured spinal cord and are required for action potential
conduction in axons passing through the injury site.
IgNrg1 isoforms are dispensable for this process; however,
compromised IgNrg1 signalling also signiﬁcantly impairs
spontaneous locomotor recovery after spinal cord injury,
likely a consequence of its role in muscle spindle mainten-
ance. However, mice in which all Nrg1 isoforms are inac-
tivated show greater functional deﬁcits than IgNrg1 speciﬁc
mutants, emphasizing the importance of Schwann cell
remyelination of dorsal column axons for optimal func-
tional recovery following spinal cord injury. Our data pro-
vide novel evidence for the molecular mechanisms that
govern a spontaneous endogenous regenerative event after
traumatic spinal cord injury, which may lead to the devel-
opment of new therapeutic strategies. Enhancing levels of
Nrg1 may accelerate this remyelination process and/or
prime the injury site to facilitate integration of transplanted
cells and/or enhance their remyelinating capacity. Schwann
cell-mediated remyelination of spinal axons is also observed
in other pathologies such as multiple sclerosis in humans
(Ghatak et al., 1973; Itoyama et al., 1985); as such, these
data may be exploited to improve or facilitate this
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regenerative process following spinal cord injury or other
pathologies where demyelination occurs.
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